GlaxoSmithKline Age of consent

The US probe into a GlaxoSmithKline manufacturing plant signals some deep problems at the UK drug maker. Regulators seemingly have lost patience with it. They have already seized pills made at the plant. The next step could be hundreds of millions of dollars of fines and the closure of the offending plant for a substantial period. Other companies, such as Schering-Plough, have been forced to disgorge hundreds of millions of profits from drugs made at sub-standard plants. Glaxo sells about $1.4bn...